Allogeneic Peripheral Blood Stem Cell Transplantation With Minimally Myelosuppressive Regimen of Pentostatin and Low-dose Total-body Irradiation.

Trial Profile

Allogeneic Peripheral Blood Stem Cell Transplantation With Minimally Myelosuppressive Regimen of Pentostatin and Low-dose Total-body Irradiation.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Dec 2010

At a glance

  • Drugs Ciclosporin; Ciclosporin; Mycophenolate mofetil; Pentostatin; Sargramostim
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; B cell lymphoma; Burkitt's lymphoma; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Cutaneous T cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Graft-versus-host disease; Hodgkin's disease; Lymphoma; MALT lymphoma; Mantle-cell lymphoma; Multiple myeloma; Mycosis fungoides; Myelodysplastic syndromes; Non-Hodgkin's lymphoma; Peripheral T-cell lymphoma; Sezary syndrome; T cell prolymphocytic leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Dec 2010 Actual number of patients is 76 as reported by ClinicalTrials.gov record.
    • 13 Mar 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top